Long COVID as a Tauopathy: Of "Brain Fog" and "Fusogen Storms"

被引:9
作者
Sfera, Adonis [1 ,2 ,3 ]
Rahman, Leah [4 ]
Zapata-Martin del Campo, Carlos Manuel [5 ]
Kozlakidis, Zisis [6 ]
机构
[1] Paton State Hosp, 3102 Highland Ave, Patton, CA 92369 USA
[2] Loma Linda Univ, Sch Behav Hlth, 11139 Anderson St, Loma Linda, CA 92350 USA
[3] Univ Calif Riverside, Dept Psychiat, 900 Univ Ave, Riverside, CA 92521 USA
[4] Univ Oregon, Dept Neurosci, 222 Huestis Hall, Eugene, OR 97401 USA
[5] Inst Natl Cardiol, Juan Badiano 1,Belisario Dominguez Secc 16, Mexico City 14080, Mexico
[6] WHO, Int Agcy Res Canc, F-69000 Lyon, France
关键词
tauopathy; phosphorylated tau; cell-cell fusion; cell senescence; taVNS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMAN ENDOGENOUS RETROVIRUSES; TRANSPOSABLE ELEMENTS; ALZHEIMERS-DISEASE; PHOSPHORYLATED TAU; VIRAL-INFECTION; CELL-FUSION; PROTEIN; INTERLEUKIN-22; ACCUMULATION;
D O I
10.3390/ijms241612648
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long COVID, also called post-acute sequelae of SARS-CoV-2, is characterized by a multitude of lingering symptoms, including impaired cognition, that can last for many months. This symptom, often called "brain fog", affects the life quality of numerous individuals, increasing medical complications as well as healthcare expenditures. The etiopathogenesis of SARS-CoV-2-induced cognitive deficit is unclear, but the most likely cause is chronic inflammation maintained by a viral remnant thriving in select body reservoirs. These viral sanctuaries are likely comprised of fused, senescent cells, including microglia and astrocytes, that the pathogen can convert into neurotoxic phenotypes. Moreover, as the enteric nervous system contains neurons and glia, the virus likely lingers in the gastrointestinal tract as well, accounting for the intestinal symptoms of long COVID. Fusogens are proteins that can overcome the repulsive forces between cell membranes, allowing the virus to coalesce with host cells and enter the cytoplasm. In the intracellular compartment, the pathogen hijacks the actin cytoskeleton, fusing host cells with each other and engendering pathological syncytia. Cell-cell fusion enables the virus to infect the healthy neighboring cells. We surmise that syncytia formation drives cognitive impairment by facilitating the "seeding" of hyperphosphorylated Tau, documented in COVID-19. In our previous work, we hypothesized that the SARS-CoV-2 virus induces premature endothelial senescence, increasing the permeability of the intestinal and blood-brain barrier. This enables the migration of gastrointestinal tract microbes and/or their components into the host circulation, eventually reaching the brain where they may induce cognitive dysfunction. For example, translocated lipopolysaccharides or microbial DNA can induce Tau hyperphosphorylation, likely accounting for memory problems. In this perspective article, we examine the pathogenetic mechanisms and potential biomarkers of long COVID, including microbial cell-free DNA, interleukin 22, and phosphorylated Tau, as well as the beneficial effect of transcutaneous vagal nerve stimulation.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
    Kondo, Asami
    Shahpasand, Koorosh
    Mannix, Rebekah
    Qiu, Jianhua
    Moncaster, Juliet
    Chen, Chun-Hau
    Yao, Yandan
    Lin, Yu-Min
    Driver, Jane A.
    Sun, Yan
    Wei, Shuo
    Luo, Man-Li
    Albayram, Onder
    Huang, Pengyu
    Rotenberg, Alexander
    Ryo, Akihide
    Goldstein, Lee E.
    Pascual-Leone, Alvaro
    McKee, Ann C.
    Meehan, William
    Zhou, Xiao Zhen
    Lu, Kun Ping
    NATURE, 2015, 523 (7561) : 431 - U118
  • [32] Use of either transcranial or whole-body photobiomodulation treatments improves COVID-19 brain fog
    Bowen, Robert
    Arany, Praveen. R. R.
    JOURNAL OF BIOPHOTONICS, 2023, 16 (08)
  • [33] BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation
    Sartori, Maxime
    Mendes, Tiago
    Desai, Shruti
    Lasorsa, Alessia
    Herledan, Adrien
    Malmanche, Nicolas
    Makinen, Petra
    Marttinen, Mikael
    Malki, Idir
    Chapuis, Julien
    Flaig, Amandine
    Vreulx, Anais-Camille
    Ciancia, Marion
    Amouyel, Philippe
    Leroux, Florence
    Deprez, Benoit
    Cantrelle, Francois-Xavier
    Marechal, Damien
    Pradier, Laurent
    Hiltunen, Mikko
    Landrieu, Isabelle
    Kilinc, Devrim
    Herault, Yann
    Laporte, Jocelyn
    Lambert, Jean-Charles
    ACTA NEUROPATHOLOGICA, 2019, 138 (04) : 631 - 652
  • [34] Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
    Bravo, Celeste Parra
    Krukowski, Karen
    Barker, Sarah
    Wang, Chao
    Li, Yaqiao
    Fan, Li
    Vazquez-Rosa, Edwin
    Shin, Min-Kyoo
    Wong, Man Ying
    McCullough, Louise D.
    Kitagawa, Ryan S.
    Choi, H. Alex
    Cacace, Angela
    Sinha, Subhash C.
    Pieper, Andrew A.
    Rosi, Susanna
    Chen, Xu
    Gan, Li
    MOLECULAR NEURODEGENERATION, 2024, 19 (01)
  • [35] Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK
    Li, Yajuan
    Munoz-Mayorga, Daniel
    Nie, Yuhang
    Kang, Ningxin
    Tao, Yuren
    Lagerwall, Jessica
    Pernaci, Carla
    Curtin, Genevieve
    Coufal, Nicole G.
    Mertens, Jerome
    Shi, Lingyan
    Chen, Xu
    CELL METABOLISM, 2024, 36 (06) : 1351 - 1370.e8
  • [36] Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy
    Rao, Shalini S.
    Lago, Larissa
    Gonzalez de Vega, Raquel
    Bray, Lisa
    Hare, Dominic J.
    Clases, David
    Doble, Philip A.
    Adlard, Paul A.
    METALLOMICS, 2020, 12 (02) : 301 - 313
  • [37] In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510
    Ishikawa, Ai
    Tokunaga, Masaki
    Maeda, Jun
    Minamihisamatsu, Takeharu
    Shimojo, Masafumi
    Takuwa, Hiroyuki
    Ono, Maiko
    Ni, Ruiqing
    Hirano, Shigeki
    Kuwabara, Satoshi
    Ji, Bin
    Zhang, Ming-Rong
    Aoki, Ichio
    Suhara, Tetsuya
    Higuchi, Makoto
    Sahara, Naruhiko
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (03) : 1037 - 1052
  • [38] Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy
    Wu, Tiffany
    Dejanovic, Borislav
    Gandham, Vineela D.
    Gogineni, Alvin
    Edmonds, Rose
    Schauer, Stephen
    Srinivasan, Karpagam
    Huntley, Melanie A.
    Wang, Yuanyuan
    Wang, Tzu-Ming
    Hedehus, Maj
    Barck, Kai H.
    Stark, Maya
    Ngu, Hai
    Foreman, Oded
    Meilandt, William J.
    Elstrott, Justin
    Chang, Michael C.
    Hansen, David, V
    Carano, Richard A. D.
    Sheng, Morgan
    Hanson, Jesse E.
    CELL REPORTS, 2019, 28 (08): : 2111 - +
  • [39] The Effects of a Blood-Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy
    Yang, Joshua
    Ou, Weijun
    Jagadeesan, Nataraj
    Simanauskaite, Juste
    Sun, Jiahong
    Castellanos, Demi
    Cribbs, David H.
    Sumbria, Rachita K.
    PHARMACEUTICALS, 2023, 16 (04)
  • [40] Review: Tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?
    Ho, Wing-Lau
    Leung, Yen
    Tsang, Andrea Wing-Ting
    So, Kwok-Fai
    Chiu, Kin
    Chang, Raymond Chuen-Chung
    MOLECULAR VISION, 2012, 18 (274-77): : 2700 - 2710